Literature DB >> 12839324

Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.

Chizu Fukushima1, Hiroto Matsuse, Shinya Tomari, Yasushi Obase, Yoshitsugu Miyazaki, Terufumi Shimoda, Shigeru Kohno.   

Abstract

BACKGROUND: Inhaled steroids such as fluticasone propionate and beclomethasone dipropionate play a central role in the treatment of bronchial asthma. Fluticasone exhibits excellent clinical effectiveness; however, oral adverse effects can occur.
OBJECTIVE: To compare the frequency of oral candidiasis in asthmatic patients treated with fluticasone and beclomethasone, to evaluate the effect of gargling with amphotericin B, and to measure the inhalation flow rate on candidiasis.
METHODS: The study consisted of 143 asthmatic patients who were treated with inhaled steroids, 11 asthmatic patients not treated with inhaled steroids, and 86 healthy volunteers. Quantitative fungal culture was performed by aseptically obtaining a retropharyngeal wall swab from these patients. Patients with positive results were treated with gargling using a 1:50 dilution amphotericin B solution. In asthmatic patients treated with fluticasone, the inhalation flow rate was measured using an inspiratory flow meter.
RESULTS: The amount of Candida spp. was significantly greater in asthmatic patients taking inhaled steroids compared with those who were not. It was also significantly greater in patients with oral symptoms than asymptomatic patients and significantly greater in asthmatic patients treated with fluticasone than in those treated with beclomethasone. Although the presence of Candida did not correlate with the inhaled dose of beclomethasone, it did increase with the dose of fluticasone. Gargling with amphotericin B was effective in most asthmatic patients with candidiasis. Candidiasis was not due to inappropriate flow rates during inhalation of steroids.
CONCLUSIONS: Fungal culture of a retropharyngeal wall swab may be useful for predicting the risk of developing oral candidiasis in asthmatic patients treated with inhaled steroids. The amount of isolated Candida was significantly greater in asthmatic patients treated with fluticasone than in those treated with beclomethasone. Attention to dosage is required as the amount of Candida increased with dose of fluticasone. Gargling with a 1:50 dilution of amphotericin B is effective in treating oral candidiasis of asthmatic patients treated with inhaled steroids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839324     DOI: 10.1016/S1081-1206(10)61870-4

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  19 in total

1.  The Sophora flavescens flavonoid compound trifolirhizin inhibits acetylcholine induced airway smooth muscle contraction.

Authors:  Nan Yang; Banghao Liang; Kamal Srivastava; Jia Zeng; Jixun Zhan; LaVerne Brown; Hugh Sampson; Joseph Goldfarb; Charles Emala; Xiu-Min Li
Journal:  Phytochemistry       Date:  2013-08-27       Impact factor: 4.072

Review 2.  Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine.

Authors:  Xiu-Min Li
Journal:  Mt Sinai J Med       Date:  2011 Sep-Oct

3.  Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model.

Authors:  Patricia I Diaz; Zhihong Xie; Takanori Sobue; Angela Thompson; Basak Biyikoglu; Austin Ricker; Laertis Ikonomou; Anna Dongari-Bagtzoglou
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

4.  The Frequency and Risk Factors for Oropharyngeal Candidiasis in Adult Asthma Patients Using Inhaled Corticosteroids.

Authors:  Tuba Erdoğan; Gül Karakaya; A Fuat Kalyoncu
Journal:  Turk Thorac J       Date:  2019-01-31

5.  Pathogenesis and treatment of oral candidosis.

Authors:  David Williams; Michael Lewis
Journal:  J Oral Microbiol       Date:  2011-01-28       Impact factor: 5.474

6.  Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study.

Authors:  Vanessa Cooper; Leanne Metcalf; Jenny Versnel; Jane Upton; Samantha Walker; Rob Horne
Journal:  NPJ Prim Care Respir Med       Date:  2015-07-09       Impact factor: 2.871

Review 7.  Clinical and microbiological diagnosis of oral candidiasis.

Authors:  Laura Coronado-Castellote; Yolanda Jiménez-Soriano
Journal:  J Clin Exp Dent       Date:  2013-12-01

Review 8.  The use of inhaled corticosteroids in pediatric asthma: update.

Authors:  Elham Hossny; Nelson Rosario; Bee Wah Lee; Meenu Singh; Dalia El-Ghoneimy; Jian Yi Soh; Peter Le Souef
Journal:  World Allergy Organ J       Date:  2016-08-12       Impact factor: 4.084

Review 9.  Treatment of eosinophilic esophagitis: drugs, diet, or dilation?

Authors:  Ameesh Shah; Ikuo Hirano
Journal:  Curr Gastroenterol Rep       Date:  2007-06

10.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.

Authors:  Julie R Brahmer; Hamzah Abu-Sbeih; Paolo Antonio Ascierto; Jill Brufsky; Laura C Cappelli; Frank B Cortazar; David E Gerber; Lamya Hamad; Eric Hansen; Douglas B Johnson; Mario E Lacouture; Gregory A Masters; Jarushka Naidoo; Michele Nanni; Miguel-Angel Perales; Igor Puzanov; Bianca D Santomasso; Satish P Shanbhag; Rajeev Sharma; Dimitra Skondra; Jeffrey A Sosman; Michelle Turner; Marc S Ernstoff
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.